title: The rate of transformation from JAK2-mutated ET to PV is influenced by an accurate WHO-defined clinico-morphological diagnosis.
authors.affiliation: Research Foundation, Papa Giovanni XXIII Hospital Bergamo, Bergamo, Italy.
authors.forename: T
authors.initials: T
authors.lastname: Barbui
authors.affiliation: Institute of Pathology, University of Cologne, Cologne, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Thiele
authors.affiliation: Research Foundation, Papa Giovanni XXIII Hospital Bergamo, Bergamo, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Carobbio
authors.affiliation: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Vannucchi
authors.affiliation: Hematology Division, Mayo Clinic, Rochester, MN, USA.
authors.forename: A
authors.initials: A
authors.lastname: Tefferi
mesh_terms: D000328:Adult; D000368:Aged; D001369:Axons; D016208:Databases, Factual; D018450:Disease Progression; D005260:Female; D015870:Gene Expression; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation; D011087:Polycythemia Vera / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D017410:Practice Guidelines as Topic; D013920:Thrombocythemia, Essential / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2